The University of Chicago Header Logo

Kerstin Stenson

Concepts (429)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Head and Neck Neoplasms
62
2026
1091
3.800
Why?
Carcinoma, Squamous Cell
36
2022
1107
2.090
Why?
Laryngeal Neoplasms
9
2025
89
1.700
Why?
Antineoplastic Combined Chemotherapy Protocols
41
2021
2666
1.210
Why?
Chemoradiotherapy
12
2023
337
1.040
Why?
Tongue Neoplasms
6
2021
51
0.940
Why?
Neck Dissection
9
2020
67
0.840
Why?
Neoplasm Recurrence, Local
24
2022
1538
0.830
Why?
Mouth Neoplasms
5
2018
223
0.780
Why?
Drug Utilization
2
2020
65
0.720
Why?
Neoplasm Invasiveness
6
2021
583
0.650
Why?
Analgesics, Opioid
3
2021
546
0.640
Why?
Combined Modality Therapy
35
2021
1754
0.630
Why?
Head
2
2023
135
0.610
Why?
Nuclear Physics
6
2014
17
0.600
Why?
Neck
1
2019
103
0.570
Why?
Morphine
1
2019
127
0.550
Why?
Neoplasm Staging
26
2021
2087
0.550
Why?
Aged
73
2025
21986
0.540
Why?
Antineoplastic Agents
10
2016
2386
0.530
Why?
Disease-Free Survival
24
2019
1196
0.530
Why?
Retrospective Studies
33
2025
11104
0.520
Why?
Oropharyngeal Neoplasms
5
2022
152
0.500
Why?
Radiotherapy Dosage
18
2016
478
0.500
Why?
Otorhinolaryngologic Surgical Procedures
3
2021
18
0.490
Why?
Models, Theoretical
6
2014
510
0.490
Why?
Deglutition Disorders
4
2025
126
0.480
Why?
Length of Stay
2
2023
889
0.480
Why?
Middle Aged
72
2025
29642
0.480
Why?
Neoadjuvant Therapy
5
2012
477
0.460
Why?
Fluorouracil
29
2012
543
0.440
Why?
Humans
110
2026
98799
0.430
Why?
Female
82
2026
51997
0.430
Why?
Male
80
2026
47475
0.420
Why?
Follow-Up Studies
18
2020
4049
0.410
Why?
Elementary Particles
4
2014
11
0.400
Why?
Tomography, X-Ray Computed
7
2025
2680
0.390
Why?
Adult
63
2025
29698
0.390
Why?
Survival Analysis
17
2023
1530
0.390
Why?
Hydroxyurea
26
2012
233
0.380
Why?
Chondrosarcoma
2
2025
42
0.380
Why?
Treatment Outcome
32
2020
9806
0.350
Why?
Induction Chemotherapy
6
2016
152
0.340
Why?
Quinazolines
5
2012
222
0.340
Why?
Spouse Abuse
2
2001
12
0.340
Why?
Hypopharyngeal Neoplasms
1
2011
15
0.330
Why?
Neoplasms, Second Primary
6
2016
244
0.330
Why?
Tracheotomy
1
2011
18
0.330
Why?
Pneumonia, Viral
3
2020
343
0.330
Why?
Coronavirus Infections
3
2020
339
0.330
Why?
Spasm
1
2010
17
0.330
Why?
Thoracoscopy
1
2010
21
0.330
Why?
Sympathectomy
1
2010
20
0.330
Why?
Hyperhidrosis
1
2010
10
0.330
Why?
Upper Extremity
1
2010
70
0.300
Why?
Airway Obstruction
1
2011
112
0.300
Why?
Vascular Diseases
1
2010
119
0.300
Why?
Papillomavirus Infections
3
2022
311
0.300
Why?
Aged, 80 and over
27
2025
7461
0.300
Why?
Drug Prescriptions
2
2021
161
0.300
Why?
Narcotics
2
2020
74
0.300
Why?
Analgesia
2
2020
65
0.290
Why?
Cohort Studies
9
2023
3242
0.290
Why?
Ischemia
1
2010
263
0.280
Why?
Lymph Nodes
4
2009
563
0.280
Why?
Prognosis
18
2019
4139
0.270
Why?
Chemotherapy, Adjuvant
9
2012
527
0.270
Why?
Pneumonia, Aspiration
1
2007
20
0.260
Why?
Paclitaxel
16
2012
484
0.260
Why?
Pharyngeal Neoplasms
2
2024
14
0.260
Why?
Survival Rate
14
2021
2057
0.250
Why?
Betacoronavirus
2
2020
288
0.250
Why?
Adenocarcinoma
3
2021
1215
0.240
Why?
Parotid Neoplasms
2
2020
22
0.240
Why?
Preoperative Care
3
2020
420
0.240
Why?
Goiter, Substernal
1
2025
4
0.230
Why?
Lead
1
2026
35
0.230
Why?
Facial Neoplasms
2
1996
26
0.230
Why?
Disease Management
2
2020
378
0.230
Why?
Radiotherapy, Adjuvant
9
2015
325
0.220
Why?
Environmental Exposure
3
2026
410
0.220
Why?
Drinking Water
1
2026
80
0.220
Why?
Lymphatic Metastasis
2
2020
519
0.200
Why?
ErbB Receptors
4
2012
517
0.200
Why?
Fibroma
1
2023
30
0.200
Why?
Elementary Particle Interactions
2
2013
4
0.190
Why?
Esophageal Neoplasms
2
2022
355
0.190
Why?
Papillomaviridae
4
2022
184
0.190
Why?
Radiotherapy, Intensity-Modulated
4
2012
200
0.190
Why?
Otolaryngology
2
2020
59
0.180
Why?
Attitude to Health
2
2001
217
0.180
Why?
Mouth
2
2011
53
0.180
Why?
Dissection
2
2020
48
0.180
Why?
Air Pollutants
1
2024
116
0.180
Why?
Cell-Derived Microparticles
1
2022
13
0.180
Why?
Air Pollution
1
2024
119
0.180
Why?
Facial Nerve
2
2020
35
0.180
Why?
Incidence
6
2026
1798
0.180
Why?
Alphapapillomavirus
1
2022
46
0.170
Why?
Carcinoma, Adenoid Cystic
1
2022
46
0.170
Why?
Mass Screening
3
2020
753
0.170
Why?
Human papillomavirus 16
2
2019
46
0.170
Why?
Neoplasm Grading
2
2021
425
0.170
Why?
Maximum Tolerated Dose
4
2012
265
0.170
Why?
Battered Women
1
2001
2
0.170
Why?
Robotic Surgical Procedures
2
2020
425
0.170
Why?
Nurse-Patient Relations
1
2001
14
0.170
Why?
Risk Assessment
7
2019
2604
0.170
Why?
Gloves, Surgical
1
2021
7
0.170
Why?
Kaplan-Meier Estimate
6
2019
909
0.170
Why?
Neoplasm Seeding
1
2021
15
0.170
Why?
Radiography
4
2014
763
0.160
Why?
Surgical Flaps
3
2008
252
0.160
Why?
Adenolymphoma
1
2020
4
0.160
Why?
Adenoma, Pleomorphic
1
2020
9
0.160
Why?
Quality of Life
11
2012
1904
0.160
Why?
Parotid Gland
1
2020
29
0.160
Why?
Glottis
1
2020
13
0.160
Why?
Deglutition
3
2010
87
0.160
Why?
Prescriptions
1
2020
27
0.160
Why?
Otorhinolaryngologic Diseases
1
2020
9
0.160
Why?
Surgical Instruments
1
2021
70
0.160
Why?
Carcinoma
2
2012
442
0.160
Why?
Otorhinolaryngologic Neoplasms
1
2000
4
0.160
Why?
Aortic Rupture
1
2020
53
0.160
Why?
Cetuximab
2
2021
119
0.160
Why?
Point-of-Care Testing
1
2020
29
0.160
Why?
Urban Health Services
1
2020
45
0.150
Why?
Clinical Laboratory Techniques
1
2020
79
0.150
Why?
Salivary Gland Neoplasms
2
2011
88
0.150
Why?
Violence
1
2001
164
0.150
Why?
Prostheses and Implants
2
1997
132
0.150
Why?
Laryngectomy
3
2025
26
0.140
Why?
Radiotherapy
7
2011
325
0.140
Why?
Monitoring, Physiologic
1
2020
265
0.140
Why?
Infection Control
1
2020
134
0.140
Why?
Aortic Aneurysm, Abdominal
1
2020
128
0.140
Why?
Sarcoma
1
2021
222
0.140
Why?
Patient Compliance
1
2020
247
0.140
Why?
Digestive System Surgical Procedures
1
2020
153
0.140
Why?
Biopsy, Fine-Needle
1
2019
108
0.140
Why?
Pregnancy
3
2014
3286
0.140
Why?
Pain Management
1
2021
198
0.140
Why?
Radiometry
2
2004
64
0.140
Why?
Free Tissue Flaps
1
2019
57
0.140
Why?
Recovery of Function
1
2020
373
0.140
Why?
Thoracic Duct
1
2017
3
0.130
Why?
Lymphatic Diseases
1
2017
31
0.130
Why?
Biomarkers
2
2014
2026
0.130
Why?
Statistics, Nonparametric
2
2009
304
0.130
Why?
Opioid-Related Disorders
1
2021
258
0.120
Why?
Mesons
2
2014
9
0.120
Why?
Facial Bones
1
1996
36
0.120
Why?
Telemedicine
1
2020
256
0.120
Why?
Hemangiopericytoma
1
1996
2
0.120
Why?
Deoxycytidine
3
2011
218
0.120
Why?
Biocompatible Materials
1
1997
205
0.120
Why?
Clinical Trials, Phase II as Topic
5
2013
168
0.110
Why?
Mouth Mucosa
1
1996
72
0.110
Why?
Immunotherapy
1
2021
831
0.110
Why?
Probability
5
2008
356
0.110
Why?
Laparoscopy
1
2022
800
0.110
Why?
Chorionic Gonadotropin
1
2014
69
0.110
Why?
Neutrons
1
2014
57
0.100
Why?
Adenomatous Polyposis Coli
1
2014
44
0.100
Why?
Tumor Virus Infections
1
2014
83
0.100
Why?
Lymphoma, Non-Hodgkin
1
1996
262
0.100
Why?
Risk Factors
6
2014
6295
0.100
Why?
Cicatrix
1
1994
78
0.100
Why?
Cosmetics
1
1993
7
0.100
Why?
Caustics
1
1993
4
0.100
Why?
Embolization, Therapeutic
1
2017
338
0.100
Why?
Burns, Chemical
1
1993
12
0.100
Why?
Esophagoscopy
2
2010
91
0.100
Why?
Pharynx
1
1993
44
0.100
Why?
Facial Injuries
1
1993
26
0.100
Why?
Laryngostenosis
1
1993
18
0.090
Why?
Carcinoma, Papillary
1
2014
166
0.090
Why?
Cartilage
1
1993
74
0.090
Why?
Tracheal Stenosis
1
1993
27
0.090
Why?
Prospective Studies
6
2021
4837
0.090
Why?
Organ Preservation
2
2011
140
0.090
Why?
Protons
1
2013
102
0.090
Why?
Burns
1
1994
150
0.090
Why?
DNA Repair
1
2014
363
0.090
Why?
Dose-Response Relationship, Radiation
2
2009
193
0.090
Why?
Adolescent
9
2020
10168
0.090
Why?
Nasopharyngeal Neoplasms
1
2012
48
0.090
Why?
Radiation-Sensitizing Agents
1
2012
99
0.090
Why?
Intracellular Signaling Peptides and Proteins
1
2014
405
0.090
Why?
SEER Program
2
2026
252
0.090
Why?
Remission Induction
6
2016
764
0.090
Why?
Speech
2
2010
91
0.090
Why?
Lymph Node Excision
1
2013
238
0.090
Why?
Postoperative Complications
3
2020
2719
0.090
Why?
Lymphangioma
1
1991
15
0.080
Why?
Organ Sparing Treatments
1
2011
54
0.080
Why?
Supraglottitis
1
2011
3
0.080
Why?
Databases, Factual
3
2021
1102
0.080
Why?
Iloprost
1
2010
14
0.080
Why?
Infusions, Parenteral
1
2010
47
0.080
Why?
Salvage Therapy
2
2023
241
0.080
Why?
Margins of Excision
2
2021
50
0.080
Why?
Prenatal Care
2
2001
81
0.080
Why?
Contrast Media
2
2009
1014
0.080
Why?
Tongue
2
2021
60
0.080
Why?
Carboplatin
6
2012
331
0.080
Why?
Esophageal Stenosis
1
2010
25
0.080
Why?
Vasodilator Agents
1
2010
133
0.080
Why?
Illinois
3
2007
531
0.080
Why?
Proportional Hazards Models
3
2021
925
0.080
Why?
Drug Resistance
1
2010
234
0.080
Why?
Osteoradionecrosis
1
2010
18
0.080
Why?
Granulocyte Colony-Stimulating Factor
3
2000
158
0.080
Why?
Dilatation
1
2010
47
0.080
Why?
Pandemics
3
2020
923
0.080
Why?
Thyroid Neoplasms
1
2014
470
0.070
Why?
Multivariate Analysis
4
2019
1007
0.070
Why?
Confidence Intervals
2
2008
221
0.070
Why?
Young Adult
4
2020
7598
0.070
Why?
Dose-Response Relationship, Drug
2
2012
1949
0.070
Why?
United States
5
2026
8387
0.070
Why?
Radiotherapy, High-Energy
1
2008
43
0.070
Why?
Skin
1
2012
592
0.070
Why?
Antibodies, Monoclonal
3
2010
1422
0.070
Why?
Bevacizumab
4
2011
255
0.070
Why?
Algorithms
2
2021
2005
0.070
Why?
Pilot Projects
2
2022
978
0.070
Why?
Biopsy
2
2009
1226
0.070
Why?
DNA-Binding Proteins
1
2014
1275
0.070
Why?
Pain Measurement
2
2020
403
0.070
Why?
Postoperative Care
1
2009
239
0.070
Why?
Genomics
1
2014
914
0.070
Why?
Recurrence
1
2010
1274
0.060
Why?
Vascular Endothelial Growth Factor A
1
2009
402
0.060
Why?
Taxoids
1
2007
127
0.060
Why?
Predictive Value of Tests
2
2009
1792
0.060
Why?
DNA
1
2012
1274
0.060
Why?
Time Factors
6
2012
5586
0.060
Why?
Dysphonia
1
2025
7
0.060
Why?
Surveys and Questionnaires
4
2020
3058
0.060
Why?
Cough
1
2025
61
0.060
Why?
Dyspnea
1
2025
91
0.050
Why?
Cell Dedifferentiation
1
2025
10
0.050
Why?
Recombinant Proteins
5
2010
994
0.050
Why?
Thyroidectomy
1
2025
181
0.050
Why?
Wound Healing
2
2000
385
0.050
Why?
Laryngoscopy
1
2025
51
0.050
Why?
Radiotherapy, Conformal
1
2005
88
0.050
Why?
Carotid Body Tumor
1
2004
4
0.050
Why?
Fatal Outcome
1
2025
295
0.050
Why?
Practice Guidelines as Topic
2
2021
1116
0.050
Why?
Neoplasms, Unknown Primary
1
2003
13
0.050
Why?
Disease Progression
5
2011
1621
0.050
Why?
Maxillary Neoplasms
1
2003
7
0.050
Why?
Antibodies, Monoclonal, Humanized
4
2011
1105
0.050
Why?
Carcinoma, Verrucous
1
2003
7
0.050
Why?
Cancer Care Facilities
1
2003
43
0.050
Why?
Radiation Dosage
2
2003
233
0.050
Why?
Maxillary Sinus
1
2003
21
0.050
Why?
Feasibility Studies
3
2000
818
0.050
Why?
Travel
1
2003
80
0.050
Why?
Antineoplastic Agents, Phytogenic
2
2012
272
0.040
Why?
Particulate Matter
1
2024
138
0.040
Why?
Neoplasm Metastasis
4
2012
1102
0.040
Why?
Drug Administration Schedule
4
2010
837
0.040
Why?
Intubation, Intratracheal
2
1993
160
0.040
Why?
Rape
1
2001
17
0.040
Why?
Child Abuse, Sexual
1
2001
19
0.040
Why?
Retreatment
2
2012
106
0.040
Why?
Biology
1
2022
54
0.040
Why?
Phototherapy
1
2021
33
0.040
Why?
Nursing Methodology Research
1
2001
11
0.040
Why?
Maternal Welfare
1
2001
8
0.040
Why?
Smoking
3
2014
676
0.040
Why?
Esophagectomy
1
2022
94
0.040
Why?
Sweden
1
2001
50
0.040
Why?
Case-Control Studies
1
2006
2017
0.040
Why?
Cytological Techniques
1
2021
30
0.040
Why?
Trachea
1
2022
246
0.040
Why?
Immunohistochemistry
3
2014
1818
0.040
Why?
Cisplatin
4
2010
578
0.040
Why?
Barium Sulfate
1
2000
37
0.040
Why?
Interferon-alpha
3
2010
191
0.040
Why?
United Kingdom
1
2020
217
0.040
Why?
Child
3
2012
7771
0.040
Why?
Registries
1
2006
1133
0.040
Why?
Fluoroscopy
1
2000
139
0.040
Why?
Pregnancy Outcome
1
2001
285
0.040
Why?
Disease Transmission, Infectious
1
2020
56
0.040
Why?
Severity of Illness Index
1
2025
2025
0.040
Why?
Tertiary Care Centers
1
2020
131
0.040
Why?
Emergencies
1
2020
126
0.040
Why?
Patient Selection
1
2003
725
0.040
Why?
Medical Oncology
1
2003
426
0.040
Why?
Chicago
2
2020
1520
0.040
Why?
Genetic Heterogeneity
1
2019
72
0.040
Why?
Multicenter Studies as Topic
2
2013
195
0.040
Why?
Uracil
1
1999
58
0.040
Why?
Oxidoreductases
1
1999
112
0.030
Why?
Video Recording
1
2000
217
0.030
Why?
Pregnancy Complications
1
2001
371
0.030
Why?
Abortion, Induced
1
2001
169
0.030
Why?
Socioeconomic Factors
1
2021
675
0.030
Why?
Cross-Sectional Studies
2
2001
2077
0.030
Why?
Gene Expression Profiling
2
2014
1572
0.030
Why?
Reference Values
1
2019
608
0.030
Why?
Voice
2
1999
18
0.030
Why?
Cyclin-Dependent Kinase Inhibitor p16
1
2018
110
0.030
Why?
Stainless Steel
1
1997
4
0.030
Why?
Alloys
1
1997
10
0.030
Why?
Lymphography
1
2017
25
0.030
Why?
Titanium
1
1997
27
0.030
Why?
Enteral Nutrition
1
2018
103
0.030
Why?
Durapatite
1
1997
36
0.030
Why?
Polyesters
1
1997
44
0.030
Why?
Scattering, Radiation
1
1997
122
0.030
Why?
Camptothecin
2
2010
198
0.030
Why?
Granuloma, Foreign-Body
1
1997
7
0.030
Why?
Vocal Cord Paralysis
1
1997
27
0.030
Why?
Polytetrafluoroethylene
1
1997
72
0.030
Why?
Clinical Decision-Making
1
2019
306
0.030
Why?
Leucovorin
2
2010
205
0.030
Why?
Quality Improvement
1
2021
538
0.030
Why?
Infant
2
1993
3368
0.030
Why?
Thyroid Diseases
1
1997
108
0.030
Why?
Everolimus
1
2016
35
0.030
Why?
Patient Satisfaction
1
1999
519
0.030
Why?
Apoptosis
1
2022
1754
0.030
Why?
Antimetabolites, Antineoplastic
2
2012
246
0.030
Why?
Administration, Oral
3
2003
677
0.030
Why?
Markov Chains
1
2015
155
0.030
Why?
Thyroid Gland
1
1997
297
0.030
Why?
Quality-Adjusted Life Years
1
2015
170
0.030
Why?
Human papillomavirus 18
1
2014
22
0.030
Why?
Odds Ratio
2
2008
728
0.030
Why?
Gene Knockout Techniques
1
2014
85
0.030
Why?
Protein Interaction Maps
1
2014
54
0.030
Why?
Electrons
1
2014
52
0.030
Why?
Immunoblotting
1
2014
273
0.030
Why?
Drug Packaging
1
1993
7
0.030
Why?
Analysis of Variance
2
2006
890
0.020
Why?
Age Factors
1
2018
1976
0.020
Why?
Child Welfare
1
1993
44
0.020
Why?
Regression Analysis
2
2009
578
0.020
Why?
Traction
1
1993
8
0.020
Why?
Pulmonary Atelectasis
1
1993
19
0.020
Why?
DNA Copy Number Variations
1
2014
207
0.020
Why?
Alcohol Drinking
2
2011
302
0.020
Why?
Thermodynamics
1
2014
327
0.020
Why?
HeLa Cells
1
2014
520
0.020
Why?
Electrocoagulation
1
1993
23
0.020
Why?
Tracheostomy
1
1993
48
0.020
Why?
Cost-Benefit Analysis
1
2015
521
0.020
Why?
Laser Coagulation
1
1993
56
0.020
Why?
Platinum
1
2012
68
0.020
Why?
Suture Techniques
1
1993
142
0.020
Why?
Pneumonia
1
1993
195
0.020
Why?
Sensitivity and Specificity
1
2015
1946
0.020
Why?
Chemoradiotherapy, Adjuvant
1
2011
40
0.020
Why?
In Situ Hybridization, Fluorescence
1
2012
369
0.020
Why?
Pemetrexed
1
2011
76
0.020
Why?
Glutamates
1
2011
85
0.020
Why?
Radiotherapy Planning, Computer-Assisted
1
2012
215
0.020
Why?
Clinical Trials, Phase I as Topic
1
2011
154
0.020
Why?
Diagnosis, Differential
1
2014
1571
0.020
Why?
Guanine
1
2011
194
0.020
Why?
Genetic Therapy
1
2012
374
0.020
Why?
Gastrostomy
1
2010
68
0.020
Why?
Postoperative Period
1
2010
325
0.020
Why?
Treatment Failure
1
2010
300
0.020
Why?
Precision Medicine
1
2014
512
0.020
Why?
Infusions, Intravenous
2
2001
403
0.020
Why?
Research Design
1
2013
652
0.020
Why?
Transforming Growth Factor alpha
1
2009
49
0.020
Why?
Erlotinib Hydrochloride
1
2009
88
0.020
Why?
Vascular Endothelial Growth Factor Receptor-2
1
2009
82
0.020
Why?
Thoracic Arteries
1
2008
4
0.020
Why?
Microcirculation
1
2008
101
0.020
Why?
Area Under Curve
1
2008
341
0.020
Why?
Microsurgery
1
2008
122
0.020
Why?
Anastomosis, Surgical
1
2008
291
0.010
Why?
Angiogenesis Inhibitors
1
2008
281
0.010
Why?
Forearm
1
2006
33
0.010
Why?
Fascia
1
2006
32
0.010
Why?
Thigh
1
2006
42
0.010
Why?
Lung
1
1993
1409
0.010
Why?
Child, Preschool
1
1993
4053
0.010
Why?
Reoperation
1
2008
730
0.010
Why?
Biopsy, Needle
1
2004
225
0.010
Why?
Angiography
1
2004
195
0.010
Why?
Mitogen-Activated Protein Kinase 3
1
2003
68
0.010
Why?
Signal Transduction
1
2014
3642
0.010
Why?
Intubation, Gastrointestinal
1
2003
30
0.010
Why?
Hospitals, University
1
2003
192
0.010
Why?
Bias
1
2003
140
0.010
Why?
Cause of Death
1
2004
279
0.010
Why?
Erythropoietin
1
2003
90
0.010
Why?
Mitogen-Activated Protein Kinases
1
2003
218
0.010
Why?
Mutation
1
2014
4443
0.010
Why?
Graft Survival
1
2006
999
0.010
Why?
Comorbidity
1
2004
1037
0.010
Why?
Referral and Consultation
1
2003
419
0.010
Why?
Tretinoin
1
2000
130
0.010
Why?
Evaluation Studies as Topic
1
1999
244
0.010
Why?
Dihydrouracil Dehydrogenase (NADP)
1
1999
28
0.010
Why?
Magnetic Resonance Imaging
1
1991
3622
0.010
Why?
Clinical Trials as Topic
1
2004
1128
0.010
Why?
Activities of Daily Living
1
1999
214
0.010
Why?
Choice Behavior
1
1999
165
0.010
Why?
Health Status
1
1999
388
0.010
Why?
Enzyme Inhibitors
1
1999
641
0.010
Why?
Diet
1
1999
472
0.010
Why?
Tumor Cells, Cultured
1
1995
1029
0.010
Why?
Decision Making
1
1999
691
0.010
Why?
Reproducibility of Results
1
1999
2799
0.010
Why?
Yttrium
1
1993
3
0.010
Why?
Aluminum Silicates
1
1993
2
0.010
Why?
Neodymium
1
1993
2
0.010
Why?
Smoke Inhalation Injury
1
1993
7
0.010
Why?
Hypertrophy
1
1993
65
0.010
Why?
Respiratory Muscles
1
1993
27
0.010
Why?
Smoke
1
1993
29
0.010
Why?
Blood Vessels
1
1993
93
0.010
Why?
Pulmonary Alveoli
1
1993
71
0.010
Why?
Pulmonary Emphysema
1
1993
44
0.010
Why?
Rats, Sprague-Dawley
1
1993
1256
0.000
Why?
Rats
1
1993
4079
0.000
Why?
Animals
2
1995
29045
0.000
Why?
Stenson's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (429)
Explore
_
Co-Authors (33)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_